Dr. Reddy's Labs Files 6-K, Confirms 20-F Reporting
Ticker: RDY · Form: 6-K · Filed: Oct 14, 2025 · CIK: 1135951
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
DRL filed a 6-K, confirming they'll file annual reports on Form 20-F. Standard procedure.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 14, 2025, reporting as a foreign private issuer. The filing indicates the company is submitting its annual reports under Form 20-F. The company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, India.
Why It Matters
This filing confirms Dr. Reddy's Laboratories' ongoing compliance with SEC reporting requirements as a foreign private issuer, which is standard for companies with international operations listed on US exchanges.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming reporting status and providing basic company information.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-25-000611 (accession_number) — Filing identifier
- 20251014 (date) — Filing date
- 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India (address) — Principal executive office
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, confirming the company's reporting status and providing basic information.
Which form will Dr. Reddy's Laboratories use for its annual reports?
Dr. Reddy's Laboratories will file its annual reports under cover of Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on October 14, 2025.
Where is Dr. Reddy's Laboratories' principal executive office located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the Commission File Number for Dr. Reddy's Laboratories?
The Commission File Number is 1-15182.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-10-14 06:19:59
Filing Documents
- rdy0808_6k.htm (6-K) — 43KB
- rdy0808_ex99-1.htm (EX-99.1) — 38KB
- rdy0808_ex99-1img01.jpg (GRAPHIC) — 11KB
- rdy0808_ex99-1img02.jpg (GRAPHIC) — 10KB
- rdy0808_ex99-1img03.jpg (GRAPHIC) — 27KB
- 0001575872-25-000611.txt ( ) — 149KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: October 13, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3